Beta Blocker De-prescription Following Coronary Artery Bypass Graft Surgery (BEEFBURGER Trial).
Conditions: Coronary Artery Disease; Acute Myocardial Infarction; Coronary Artery Stenosis; ST Elevation Myocardial Infarction; Non-ST Elevation Myocardial Infarction (NSTEMI) Intervention: Drug: De-prescribe beta blocker therapy Sponsors: University of Saskatchewan; Canadian VIGOUR Centre Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 9, 2021 Category: Research Source Type: clinical trials
Beta Blocker Use in Cardiac Surgery and Association With Postoperative Course
Condition: Cardiac Surgery With Cardiopulmonary Bypass Interventions: Other: collection of the allocated treatment; Other: collection of medical complications Sponsor: Centre Hospitalier Universitaire Dijon Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 24, 2021 Category: Research Source Type: clinical trials
Long-term Beta-blocker Therapy After Acute Myocardial Infarction
Condition: Myocardial Infarction Intervention: Drug: Discontinuation of β-blocker Sponsors: Samsung Medical Center; Kangbuk Samsung Hospital; Gyeongsang National University Hospital; Kyung Hee University Hospital; Keimyung University Dongsan Medical Center; Korea University Anam Hospital; Sejong General Hospital; Seoul National University Bund ang Hospital; Samsung Changwon Hospital; Saint Vincent's Hospital, Korea; Presbyterian medical center; Wonkwang University Hospital; Wonju Severance Christian Hospital; Ewha Womans University S...
Source: ClinicalTrials.gov - February 24, 2021 Category: Research Source Type: clinical trials
Beta Blocker Use in Cardiac Surgery and Association With Postoperative Course
Condition: Cardiac Surgery With Cardiopulmonary Bypass Interventions: Other: collection of the allocated treatment; Other: collection of medical complications Sponsor: Centre Hospitalier Universitaire Dijon Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 24, 2021 Category: Research Source Type: clinical trials
Long-term Beta-blocker Therapy After Acute Myocardial Infarction
Condition: Myocardial Infarction Intervention: Drug: Discontinuation of β-blocker Sponsors: Samsung Medical Center; Kangbuk Samsung Hospital; Gyeongsang National University Hospital; Kyung Hee University Hospital; Keimyung University Dongsan Medical Center; Korea University Anam Hospital; Sejong General Hospital; Seoul National University Bund ang Hospital; Samsung Changwon Hospital; Saint Vincent's Hospital, Korea; Presbyterian medical center; Wonkwang University Hospital; Wonju Severance Christian Hospital; Ewha Womans University S...
Source: ClinicalTrials.gov - February 24, 2021 Category: Research Source Type: clinical trials
